Fabtech TechnologiesNSE:FABTECH -0.49%20 EBITDA Margin % is 20.22% as of Mar. 2026, which is 21% above its 10-year median of 16.76. GuruFocus rates NSE:FABTECH with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Fabtech Technologies ranks better than 56.09% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Fabtech Technologies EBITDA Margin % Related Terms
Fabtech Technologies EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Fabtech Technologies's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:FABTECH vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, Fabtech Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fabtech Technologies EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fabtech Technologies's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Fabtech Technologies's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabtech Technologies (NSE:FABTECH) has a EBITDA Margin % of 20.22% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Fabtech Technologies and its competitors. This is 21% above median its historical median of 16.76. Over the past decade, Fabtech Technologies' EBITDA Margin % has ranged from 12.45 to 19.94. According to the industry distribution chart, Fabtech Technologies ranks #292 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 43.9%.
Is Fabtech Technologies' EBITDA Margin % too high?
Fabtech Technologies' current EBITDA Margin % of 20.22% is 21% above median its 10-year median of 16.76. Over the past 10 years, this metric has ranged from a low of 12.45 to a high of 19.94. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Fabtech Technologies' value of 20.22% is 97.5% above this industry median. Based on the distribution chart, Fabtech Technologies ranks #292 out of 665 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fabtech Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Fabtech Technologies' EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Fabtech Technologies ranks #292 out of 665 companies for EBITDA Margin %. This puts Fabtech Technologies in the upper half of its industry. The industry median EBITDA Margin % is 10.24. Fabtech Technologies' value of 20.22% is 97.5% above this benchmark. Historically, Fabtech Technologies' own EBITDA Margin % has ranged from 12.45 to 19.94 over the past decade. While the company's 10-year median is 16.76 vs. the industry median of 10.24, Fabtech Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fabtech Technologies's current EBITDA Margin % of 20.22% is 97.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Fabtech Technologies and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fabtech Technologies's current EBITDA Margin % is 20.22%, which is 21% above median its own 10-year median of 16.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabtech Technologies stock overvalued right now?
Fabtech Technologies (NSE:FABTECH) has a current EBITDA Margin % of 20.22%. The current EBITDA Margin % is 20.22%, which is 21% above median its 10-year median of 16.76 and 97.5% above the Healthcare Providers & Services industry median of 10.24. Fabtech Technologies' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Fabtech Technologies (NSE:FABTECH), the current EBITDA Margin % is 20.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fabtech Technologies Ltd is engaged in building pharmaceutical, biotech, and healthcare capabilities for a wide range of customers by offering comprehensive start-to-finish turnkey solutions, which include supplying pharmaceutical machinery/equipment, in-house designing and engineering, procurement, installation, validation, and undertaking other activities required in various projects, including standalone equipment supply and installation. The company provides solutions for clean air, manufacturing processes, purified water and pure steam generation and distribution, etc. The majority of its revenue is generated from the trading of pharmaceutical and surgical products. Geographically, the company derives maximum revenue from international markets, and the rest from its business in India.
20GF Score
Get the complete analysis for NSE:FABTECH
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:FABTECH has been successfully added to your 